A. Kumor

发表

ADIPOHORMONES AS PROGNOSTIC MARKERS IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH)

A. Jasińska, D. Orszulak-Michalak, E. Małecka-Panas, 2009 .

D-dimers revisited: a new marker of pancreatic cancer.

P. Grzelak, A. Durczyński, J. Strzelczyk, 2014, American journal of clinical oncology.

Insulin, insulin-like growth factor 1 and insulin-like growth factor binding protein 3 serum concentrations in patients with adenomatous colon polyps

E. Małecka-Panas, R. Talar-Wojnarowska, A. Janiak, 2013, Przeglad gastroenterologiczny.

Predicting Maximum Roux-en-Y Gastric Bypass-Induced Weight Reduction — Preoperative Plasma Leptin or Body Weight?

L. Czupryniak, J. Strzelczyk, M. Pawłowski, 2007, Obesity surgery.

Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients

E. Małecka-Panas, A. Kumor, M. Pietruczuk, 2009, International Journal of Colorectal Disease.

Pancreatic head carcinoma and vascular endothelial growth factor (VEGF-A) concentration in portal blood: its association with cancer grade, tumor size and probably poor prognosis

A. Durczyński, J. Strzelczyk, P. Hogendorf, 2014, Archives of medical science : AMS.

A Panel of CA19-9, Ca125, and Ca15-3 as the Enhanced Test for the Differential Diagnosis of the Pancreatic Lesion

A. Skulimowski, A. Durczyński, J. Strzelczyk, 2017, Disease markers.

Growth differentiation factor (GDF-15) concentration combined with Ca125 levels in serum is superior to commonly used cancer biomarkers in differentiation of pancreatic mass.

A. Skulimowski, A. Durczyński, J. Strzelczyk, 2017, Cancer biomarkers : section A of Disease markers.

Neutrophil Gelatinase-Associated Lipocalin (NGAL) concentration in urine is superior to CA19-9 and Ca 125 in differentiation of pancreatic mass: Preliminary report.

A. Skulimowski, A. Durczyński, J. Strzelczyk, 2016, Cancer biomarkers : section A of Disease markers.

[Serum concentration of insulin, C-peptide and insulin-like growth factor I in patients with colon adenomas and colorectal cancer].

E. Małecka-Panas, A. Kaczka, A. Kumor, 2007, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego.

Serum concentrations of insulin, insulin-like growth factor I, vascular endothelial growth factor and gastrin in patients with colon adenomas and colorectal cancer

E. Małecka-Panas, A. Kaczka, A. Kumor, 2012 .

Preoperative high level of D-dimers predicts unresectability of pancreatic head cancer.

P. Grzelak, A. Durczyński, J. Strzelczyk, 2014, World journal of gastroenterology.

Gender-Specific Coagulation Profiles of Peripheral and Portal Blood May Help to Differentiate Malignant from Benign Pancreatic Tumour—Pilot Study

A. Durczyński, J. Strzelczyk, W. Ciesielski, 2022, Journal of clinical medicine.

Concentration of D-dimers in Bile-a Novel Marker of Pancreatic Cancer Enhancing Accuracy of Standard CA19-9 Measurement: Dual Test Hypothesis.

Marcin Strzelczyk, P. Grzelak, A. Skulimowski, 2017, Pancreas.

Prostaglandin E2 (PGE2) in Portal Blood in Patients with Pancreatic Tumor—A Single Institution Series

A. Durczyński, J. Strzelczyk, P. Hogendorf, 2012, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

Adipohormones as prognostric markers in patients with nonalcoholic steatohepatitis (NASH).

A. Jasińska, D. Orszulak-Michalak, E. Małecka-Panas, 2009, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

The concentration of D-dimers in portal blood positively correlates with overall survival in patients with non-resectable pancreatic cancer

A. Skulimowski, A. Durczyński, J. Strzelczyk, 2017, World Journal of Surgical Oncology.